Literature DB >> 27323007

Clinical Phenotype and Segregation of Mitochondrial 3243A>G Mutation in 2 Pairs of Monozygotic Twins.

Kengo Maeda1, Hiromichi Kawai2, Mitsuru Sanada2, Tomoya Terashima2, Nobuhiro Ogawa1, Ryo Idehara3, Tetsuya Makiishi4, Hitoshi Yasuda2, Shun-Ichi Sato5, Ken-Ichi Hoshi5, Hiroyuki Yahikozawa5, Katsuji Nishi6, Yasushi Itoh7, Kazumasa Ogasawara7, Kazuo Tomita8, Hiroko P Indo8, Hideyuki J Majima8.   

Abstract

IMPORTANCE: The regulatory factors explaining the wide spectrum of clinical phenotypes for mitochondrial 3243A>G mutation are not known. Crosstalk between nuclear genes and mitochondrial DNA might be one factor. OBSERVATIONS: In this case series, we compared 2 pairs of male twins with the mitochondrial 3243 A>G mutation and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome with a female control patient. One pair of monozygotic twins presented with diabetes and deafness in their 30s, stroke-like episodes in their 40s, and cardiac events and death in their 50s. Another pair of twins presented with deafness and stroke-like episodes in their 20s. The degree of heteroplasmy of 3243A>G mutation in the various tissues and organs was similar in the first pair of twins compared with the control patient. CONCLUSIONS AND RELEVANCE: The clinical phenotype and segregation of mitochondrial 3243A>G mutation was similar in monozygotic twins. The onset age and distribution of the symptoms might be regulated by nuclear genes. Our findings might help to predict the clinical course of the surviving twins and afford an opportunity for therapy before the onset of mitochondrial disease, especially for monozygotic twins caused by nuclear transfer with a small amount of nuclear-donor mitochondrial DNA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27323007     DOI: 10.1001/jamaneurol.2016.0886

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  12 in total

Review 1.  Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2020-06-27       Impact factor: 4.797

2.  Sensitive quantification of m.3243A>G mutational proportion in non-retinal tissues and its relationship with visual symptoms.

Authors:  Nathaniel K Mullin; Kristin R Anfinson; Megan J Riker; Kelsey L Wieland; Nicole J Tatro; Todd E Scheetz; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

Review 3.  The rise of mitochondria in medicine.

Authors:  Martin Picard; Douglas C Wallace; Yan Burelle
Journal:  Mitochondrion       Date:  2016-07-14       Impact factor: 4.160

Review 4.  Mitochondrial DNA, nuclear context, and the risk for carcinogenesis.

Authors:  Brett A Kaufman; Martin Picard; Neal Sondheimer
Journal:  Environ Mol Mutagen       Date:  2018-01-14       Impact factor: 3.216

5.  Purifying Selection against Pathogenic Mitochondrial DNA in Human T Cells.

Authors:  Melissa A Walker; Caleb A Lareau; Leif S Ludwig; Amel Karaa; Vijay G Sankaran; Aviv Regev; Vamsi K Mootha
Journal:  N Engl J Med       Date:  2020-08-12       Impact factor: 91.245

Review 6.  Applying genomic and transcriptomic advances to mitochondrial medicine.

Authors:  William L Macken; Jana Vandrovcova; Michael G Hanna; Robert D S Pitceathly
Journal:  Nat Rev Neurol       Date:  2021-02-23       Impact factor: 42.937

7.  Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors.

Authors:  Sarah J Pickett; John P Grady; Yi Shiau Ng; Gráinne S Gorman; Andrew M Schaefer; Ian J Wilson; Heather J Cordell; Doug M Turnbull; Robert W Taylor; Robert McFarland
Journal:  Ann Clin Transl Neurol       Date:  2018-02-07       Impact factor: 4.511

8.  mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.

Authors:  John P Grady; Sarah J Pickett; Yi Shiau Ng; Charlotte L Alston; Emma L Blakely; Steven A Hardy; Catherine L Feeney; Alexandra A Bright; Andrew M Schaefer; Gráinne S Gorman; Richard Jq McNally; Robert W Taylor; Doug M Turnbull; Robert McFarland
Journal:  EMBO Mol Med       Date:  2018-06       Impact factor: 12.137

9.  Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease.

Authors:  Dar-Shong Lin; Yu-Wen Huang; Che-Sheng Ho; Pi-Lien Hung; Mei-Hsin Hsu; Tuan-Jen Wang; Tsu-Yen Wu; Tsung-Han Lee; Zo-Darr Huang; Po-Chun Chang; Ming-Fu Chiang
Journal:  Cells       Date:  2019-01-17       Impact factor: 6.600

Review 10.  The molecular pathology of pathogenic mitochondrial tRNA variants.

Authors:  Uwe Richter; Robert McFarland; Robert W Taylor; Sarah J Pickett
Journal:  FEBS Lett       Date:  2021-02-12       Impact factor: 3.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.